Edesa Biotech
EDSA
15 hedge funds and large institutions have $774K invested in Edesa Biotech in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
25% more funds holding
Funds holding: 12 → 15 (+3)
0.14% less ownership
Funds ownership: 0.29% → 0.16% (-0.14%)
15% less capital invested
Capital invested by funds: $910K → $774K (-$136K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$223K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$168K |
| 3 |
VF
Virtu Financial
New York
|
+$92.9K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$88.4K |
| 5 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$4.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$318K |
| 2 |
Renaissance Technologies
New York
|
-$315K |
| 3 |
Two Sigma Investments
New York
|
-$96K |
EDSA Hedge Fund Activity: Q1 2021 in Review
15 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2021, worth a combined $774K — down 15% from $910K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new EDSA positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $223K. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $318K sold.
- 15 institutional investors held Edesa Biotech (EDSA) as of Q1 2021, up from 12 in Q4 2020.
- Funds reported $774K of Edesa Biotech stock for Q1 2021, down 15% quarter-over-quarter.
- 6 funds opened new Edesa Biotech positions in Q1 2021 and 3 closed out, a net change of +3 holders.
- The largest Edesa Biotech buyer in Q1 2021 was Vanguard Group, an estimated $223K added.
- The largest Edesa Biotech seller in Q1 2021 was FNY Investment Advisers, an estimated $318K sold.
Based on aggregated 13F filings for Q1 2021.